BIT
SIOX

BlackRock Institutional Trust’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

BlackRock Institutional Trust’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.84M Sell
28,603
-34
-0.1% -$3.58K ﹤0.01% 2931
2016
Q3 		$3.21M Buy
28,637
+855
+3% +$103K ﹤0.01% 2868
2016
Q2 		$2.85M Buy
27,782
+12,892
+87% +$1.29M ﹤0.01% 2910
2016
Q1 		$1.37M Sell
14,890
-471
-3% -$50.2K ﹤0.01% 3192
2015
Q4 		$2.22M Buy
15,361
+2,281
+17% +$297K ﹤0.01% 3078
2015
Q3 		$1.35M Buy
+13,080
New +$1.53M ﹤0.01% 3239

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Institutional Trust's SIOX Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Sio Gene Therapies Inc. Common Stock (SIOX) stake by 0.12% in Q4 2016, selling an estimated $3.58K and leaving 28,603 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

BlackRock Institutional Trust first reported a position in SIOX in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.21M in Q3 2016. 101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

  • BlackRock Institutional Trust held 28,603 shares of Sio Gene Therapies Inc. Common Stock worth $2.84M as of Q4 2016.
  • BlackRock Institutional Trust sold 34 Sio Gene Therapies Inc. Common Stock shares in Q4 2016, an estimated $3.58K.
  • Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2931 holding.
  • BlackRock Institutional Trust first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Sio Gene Therapies Inc. Common Stock position peaked at $3.21M in Q3 2016.
  • 101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.